JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders

被引：44

作者：

Cambier, N. ^{[1
,2
,3
]}

Renneville, A. ^{[4
]}

Cazaentre, T. ^{[1
,2
,3
]}

Soenen, V. ^{[4
]}

Cossement, C. ^{[4
]}

Giraudier, S. ^{[5
,6
]}

Grardel, N. ^{[4
]}

Lai, J-L ^{[7
]}

Rose, C. ^{[1
,2
,3
]}

Preudhomme, C. ^{[2
,3
,4
]}

机构：

[1] Hop St Vincent de Paul, GHICL, Serv Hematol Clin, Lille, France

[2] INSERM, Inst Rech Canc Lille, U837, F-59045 Lille, France

[3] N W Canceropole, Lille, France

[4] CHRU Lille, Ctr Biol Pathol, Hematol Lab, Lille, France

[5] Hop Henri Mondor, AP HP, Hematol Lab, F-94010 Creteil, France

[6] Univ Paris 07, Creteil, France

[7] CHRU Lille, Hop Jeanne Flandres, Lab Cytogenet, Lille, France

来源：

LEUKEMIA | 2008年 / 22卷 / 07期

关键词：

D O I：

10.1038/sj.leu.2405088

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1454 / 1455

页数：2

共 11 条

[1] In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2V617F allele [J].

Gaikwad, Amos ;

Nussenzveig, Roberto ;

Liu, Enli ;

Gottshalk, Stephen ;

Chang, KoTung ;

Prchal, Josef T. .

EXPERIMENTAL HEMATOLOGY, 2007, 35 (04) :587-595

[2] TRANSFORMATION OF POLYCYTHEMIA-VERA TO PH-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA [J].

HAQ, AU .

AMERICAN JOURNAL OF HEMATOLOGY, 1990, 35 (02) :110-113

[3] Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation [J].

Hussein, Kais ;

Bock, Oliver ;

Seegers, Anna ;

Flasshove, Michael ;

Henneke, Felicitas ;

Buesche, Guntram ;

Kreipe, Hans Heinrich .

BLOOD, 2007, 109 (09) :4106-4107

[4] Analysis of the exon 12 and 14 mutations of the JAK2 gene in Philadelphia chromosome-positive leukemia [J].

Inami, M. ;

Yamaguchi, H. ;

Hasegawa, S. ;

Mitamura, Y. ;

Kosaka, F. ;

Kobayashi, A. ;

Kimura, S. ;

Dan, K. ;

Inokuchi, K. .

LEUKEMIA, 2008, 22 (01) :216-216

[5] Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia [J].

Inami, M. ;

Inokuchi, K. ;

Okabe, M. ;

Kosaka, F. ;

Mitamura, Y. ;

Yamaguchi, H. ;

Dan, K. .

LEUKEMIA, 2007, 21 (05) :1103-1104

[6] Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis [J].

James, C ;

Delhommeau, F ;

Marzac, C ;

Teyssandier, I ;

Le Couédic, JP ;

Giraudier, S ;

Roy, L ;

Saulnier, P ;

Lacroix, L ;

Maury, S ;

Tulliez, M ;

Vainchenker, W ;

Ugo, V ;

Casadevall, N .

LEUKEMIA, 2006, 20 (02) :350-353

[7] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].

James, C ;

Ugo, V ;

Le Couédic, JP ;

Staerk, J ;

Delhommeau, F ;

Lacout, C ;

Garçon, L ;

Raslova, H ;

Berger, R ;

Bennaceur-Griscelli, A ;

Villeval, JL ;

Constantinescu, SN ;

Casadevall, N ;

Vainchenker, W .

NATURE, 2005, 434 (7037) :1144-1148

[8] Progression from myelodysplastic syndrome to acute lymphoblastic leukaemia with Philadelphia chromosome and p190 BCR-ABL transcript [J].

Kohno, T ;

Amenomori, T ;

Atogami, S ;

Sasagawa, I ;

Nakamura, H ;

Kuriyama, K ;

Tomonaga, M .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (02) :389-391

[9]

Roumier C, 1999, HAEMATOLOGICA, V84, P1075

[10] Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis [J].

Traverse-Glehen, A. ;

Verney, A. ;

Baseggio, L. ;

Felman, P. ;

Callet-Bauchu, E. ;

Thieblemont, C. ;

Ffrench, M. ;

Magaud, J-P ;

Coiffier, B. ;

Berger, F. ;

Salles, G. .

LEUKEMIA, 2007, 21 (08) :1824-1826

← 1 2 →